Lebwohl; David
Patent Applications and Registrations
Patent applications and USPTO patent grants for Lebwohl; David.The latest application filed is for "combination therapies of egfr inhibitors".
- Lebwohl; David - East Hanover NJ
- Lebwohl; David - Madison NJ
- LEBWOHL; David - Madispm NJ
| Patent | Date |
|---|---|
| Combination therapies Grant 11,344,620 - Lebwohl , et al. May 31, 2 | 2022-05-31 |
| Combination therapies of EGFR inhibitors Grant 9,993,551 - Lebwohl , et al. June 12, 2 | 2018-06-12 |
| Combination Therapies Of Egfr Inhibitors App 20170304443 - Lebwohl; David ; et al. | 2017-10-26 |
| Combination Therapies App 20170296659 - Lebwohl; David ; et al. | 2017-10-19 |
| Combination Therapies Of Alk Inhibitors App 20170281624 - Peters; Malte ; et al. | 2017-10-05 |
| Neuroendocrine Tumor Treatment App 20170128425 - Marks; Peter Wayne ; et al. | 2017-05-11 |
| Neuroendocrine Tumor Treatment App 20150148294 - Marks; Peter Wayne ; et al. | 2015-05-28 |
| Neuroendocrine tumor treatment Grant 9,006,224 - Marks , et al. April 14, 2 | 2015-04-14 |
| Tuberous Sclerosis Treatment App 20100305150 - Berg; William ; et al. | 2010-12-02 |
| Neuroendocrine Tumor Treatment App 20080255029 - Marks; Peter Wayne ; et al. | 2008-10-16 |
| Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases Grant 7,008,936 - Voi , et al. March 7, 2 | 2006-03-07 |
| Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases App 20040024032 - Voi, Maurizio ; et al. | 2004-02-05 |
| SEC | 0001810882 | Lebwohl David |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 